Globe Life (GL) AI Stock Analysis

• Market Cap: $11.46B
• Dividend Yield: 0.73%
• Average Volume (3M): 690.59K
• Price to Earnings (P/E): 11.3
• Beta (1Y): 0.67
• Revenue Growth: 4.02%
• EPS Growth: 13.01%
• Country: US
• Employees: 3,732
• Sector: Financial
• Sector Strength: 71
• Industry: Insurance - Life
• EPS (TTM): 3.27
• Shares Outstanding: 81,003,530
• 10 Day Avg. Volume: 454,551
• 30 Day Avg. Volume: 690,594
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.14
• Enterprise Value/Revenue: 2.24
• Enterprise Value/Gross Profit: 2.68
• Enterprise Value/Ebitda: 8.95
• 1Y Price Target: $158.78
• Price Target Upside: 13.57% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 9

• Rating: 78 Outperform
• Price Target: $155.00 ▲(10.86% Upside)

Globe Life's strong financial performance and positive earnings call are the most significant factors contributing to its score. The conclusion of legal investigations further boosts confidence. While technical indicators are moderately positive, valuation remains reasonable, supporting a favorable outlook.

Positive Factors

Earnings Growth

Life underwriting income showed strong performance with 9% year-over-year growth.

Regulatory Clarity

The conclusion of the SEC and DOJ investigations should remove significant uncertainty.

Sales Enhancement

Positive underlying trends at Globe Life's Direct to Consumer arm are expected to enhance sales through leads and analytics.

Negative Factors

Earnings Performance

GL's operating EPS was below expectations, which could pressure the stock.

Sales Outlook

There is a more muted sales outlook driven by lower productivity at Globe Life's exclusive agencies following recent elevated recruiting levels.

Globe Life Business Overview & Revenue Model

Company Description

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.

How the Company Makes Money

Globe Life generates revenue primarily through the sale of insurance premiums. The company earns money by underwriting life and health insurance policies, collecting premiums from policyholders, and investing those premiums in various financial instruments, such as bonds and stocks, to yield investment income. The core revenue streams include individual life insurance products, which provide long-term financial protection, and supplemental health insurance products that cover specific health-related expenses. Furthermore, Globe Life benefits from a network of independent agents and marketing partnerships that help distribute its products, enhancing its reach and customer acquisition efforts. Additionally, the company may generate income from policy renewals and persistency, where customers continue to pay premiums for their policies over time.

Globe Life Financial Statement Overview

Summary

Globe Life demonstrates strong financial performance with consistent revenue growth and a robust net profit margin. The balance sheet shows stability with low leverage, though declining equity is a concern. Cash flow generation remains healthy, supporting operations and potential investments.

Income Statement

Globe Life has shown consistent revenue growth over the years, with a noticeable increase from 2023 to 2024. The net profit margin in 2024 was strong at approximately 18.5%, indicating efficient cost management and profitability. However, the absence of EBIT and EBITDA data for 2024 limits a complete analysis of operational efficiency.

Balance Sheet

The company exhibits a sound equity position with a debt-to-equity ratio of 0.078, indicating low leverage risk. The equity ratio of approximately 18.2% in 2024 suggests financial stability. However, the decrease in stockholders' equity over the years could be a concern if it continues.

Cash Flow

The cash flow position is robust with a stable operating cash flow. The free cash flow has been consistent, although the growth rate reduced from 2022 to 2023. The free cash flow to net income ratio suggests a strong ability to generate cash relative to net income.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	5.84B	5.78B	5.45B	5.21B	5.11B	4.74B
Gross Profit	4.89B	2.47B	5.10B	4.86B	4.79B	4.44B
EBITDA	1.46B	1.45B	1.30B	1.19B	1.36B	983.39M
Net Income	1.07B	1.07B	970.75M	894.39M	1.03B	731.77M
Balance Sheet
Total Assets	29.71B	29.08B	28.05B	25.54B	29.77B	29.05B
Cash, Cash Equivalents and Short-Term Investments	17.87B	250.36M	103.16M	16.71B	21.47B	21.42B
Total Debt	2.80B	2.74B	2.12B	2.08B	2.03B	1.92B
Total Liabilities	24.28B	23.77B	23.56B	20.64B	21.13B	20.28B
Stockholders Equity	5.43B	5.31B	4.49B	4.90B	8.64B	8.77B
Cash Flow
Free Cash Flow	1.41B	1.33B	1.43B	1.39B	1.40B	1.43B
Operating Cash Flow	1.48B	1.40B	1.48B	1.42B	1.44B	1.48B
Investing Cash Flow	-149.53M	-641.52M	-926.15M	-943.01M	-913.37M	-1.18B
Financing Cash Flow	-1.20B	-715.84M	-541.49M	-492.45M	-523.60M	-274.06M

Globe Life Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 139.81
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GL, the sentiment is Positive. The current price of 139.81 is above the 20-day moving average (MA) of 139.34, above the 50-day MA of 132.27, and above the 200-day MA of 121.98, indicating a bullish trend. The MACD of 2.01 indicates Positive momentum. The RSI at 56.89 is Neutral, neither overbought nor oversold. The STOCH value of 64.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GL.

Globe Life Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FG	80 Outperform	$4.75B	14.43	8.40%	2.52%	1.78%	0.77%
GL	78 Outperform	$11.46B	11.30	20.02%	0.73%	4.02%	13.01%
LNC	71 Outperform	$8.19B	7.55	12.97%	4.27%	11.33%	-38.17%
PRI	71 Outperform	$8.87B	13.56	31.95%	1.47%	5.70%	61.69%
UNM	69 Neutral	$12.44B	8.74	13.95%	2.33%	1.69%	22.65%
Sector *	68 Neutral	$18.06B	11.97	10.24%	3.74%	9.75%	1.30%
JXN	63 Neutral	$6.84B	82.50	0.30%	3.14%	27.18%	-100.02%

Globe Life Corporate Events

Globe Life Cleared by DOJ and SEC Investigations

On July 24, 2025, Globe Life Inc. announced the conclusion of an SEC investigation, which ended without any enforcement action against the company. Subsequently, on July 28, 2025, the Department of Justice also closed its investigation into Globe Life and its subsidiary, American Income Life Insurance Company, marking a significant relief for the company and its stakeholders.

Globe Life Completes $500M P-Caps Issuance for Liquidity

On July 1, 2025, Globe Life Inc. completed a significant financial transaction involving the issuance and sale of $500 million in Pre-Capitalized Trust Securities (P-Caps) through a private placement. This move provides the company with a source of contingent liquidity for general corporate purposes. The transaction involves a complex arrangement with the Henneman Trust and Regions Bank, allowing Globe Life to issue Senior Notes and manage its financial obligations effectively. The structure includes provisions for automatic and required exercises of issuance rights under specific financial conditions, which could impact the company’s financial stability and operations.